Tristel PLC

AGM Statement and notice of results

RNS Number : 0238X
Tristel PLC
17 December 2019
 

Tristel plc

("Tristel" of the "Company")

 

AGM Statement and notice of results

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, will hold its Annual General Meeting today at 10am at Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire CB8 7NY.

 

At the meeting Paul Swinney, Chief Executive Officer, will provide shareholders with the following update:

 

"We expect unaudited pre-tax profit (before share-based payments) for the first half to be no less than £2.8 million, compared to £2.4 million for the same period last year. The expected pre-tax profit includes a positive contribution from our operations in Belgium, the Netherlands, France and Italy which were all acquired during the past year. The Company is performing in line with management's expectations and our United States regulatory approvals project is progressing well."

 

Paul Barnes, Chairman, will add:

 

"On behalf of my Board colleagues I would like to welcome Dr Bruno Holthof to the Chair. Our Company will undoubtedly benefit from his very broad experience of global healthcare."

 

Notice of Results

The Company's unaudited interim results will be announced on Monday 24 February 2020.

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

For further information please contact:       

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer


Liz Dixon, Finance Director




Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303



finnCap

Tel: 020 7220 0500

Geoff Nash / Giles Rolls, Corporate Finance


Alice Lane, ECM

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
AGMBSBDDIGBBGCL